openPR Logo
Press release

Generative AI Chatbots Provide Instant, 24/7 Support for Investors and Medicinal Queries While Offering Personalized Recommendations: 1606 Corp (Stock Symbol: CBDW)

11-07-2024 04:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: CAP, LLC
Generative AI Chatbots Provide Instant, 24/7 Support

CBDW's New AI Platforms for Drug Discovery and Infectious Disease Research with the Power to Predict and Help Prevent Future Pandemics
- Leading Biotechnology Innovator Specializing in AI Chatbot Solutions for Early Drug Discovery, Infectious Disease and Neurodegenerative Disease Research.

- Focus on Developing Therapeutic Solutions by Leveraging Human Immune-B Cells for a Cutting-Edge Approach to Highly Effective Treatments.

- Strategic Investment Plan Demonstrating Commitment to Advancing Technological Capabilities and Expanding Reach in the AI Sector.

- Launch of Sutra (TM), a Game-Changing AI Platform for Drug Discovery and Infectious Disease Research.

- AI Platform Confirmed Decades of Work and Added New Targets for Monoclonal Antibodies with Independent Validation of Their Potential from Collaborators.

- Growing IP Portfolio Including Patents, Trademarks and Trade Secrets.

- With a Database of 19 Viruses, the Sutra Trademark AI Platform Can Predict and Help Prevent Future Pandemics.

- Harnessing the Power of AI to Revolutionize Drug Repurposing, Offering a Cost-Effective Alternative to Developing New Drugs from the Ground Up.

1606 Corp. (OTC: CBDW) is a leading innovator in biotechnology, specializing in AI-driven solutions for early drug discovery, infectious disease, and neurodegenerative disease research. CBDW proprietary methods focus on developing therapeutic solutions by leveraging human immune-B cells, offering a cutting-edge approach to creating highly effective treatments.

CBDW has announced it has signed a Letter of Intent to acquire a strategic stake in Adnexus Biotechnologies Inc. CBDW stands at the forefront of technological innovation, particularly in AI Chatbots. It's mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. CBDW is dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.

CBDW specializes in the development and licensing of AI-powered chatbots, transforming how businesses communicate with their investors. CBDW is now a revenue generating AI technology development and sales company committed to enhancing the world of chatbots through the application of conversational artificial intelligence, and currently, CBDW AI is one of the fastest growing AI focused companies on the OTC Markets.

Generative AI Chatbots can provide instant, round-the-clock support, guiding potential investors through the company. Queries about dosage, usage, legality, while offering personalized recommendations based on individual preferences. Moreover, CBDW chatbots can handle multiple interactions simultaneously, ensuring no potential or existing investor feels neglected due to long response times. They also collect valuable data on investor preferences and behaviors, allowing companies to tailor their communication strategies more effectively. In the investor relations industry, where transparency and timely information are paramount, CBDW chatbots can provide up-to-date details on earnings reports, stock performance and company news. This immediate access to information builds confidence with investors, encouraging them to make informed decisions.

The global artificial intelligence market has seen remarkable growth, valued at $428 billion in 2022 and projected to reach $2.25 trillion by 2030. With a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%, AI's global impact is undeniable, with as many as 97 million individuals expected to work in the AI sector by 2025, according to fortunebusinessinsights.com

Unveils Sutra (TM) is a Game-Changing AI Platform for Drug Discovery and Infectious Disease Research

On October 1st CBDW announced its new AI Empowered Drug Discovery Platform, Sutra Trademark .

The CBDW Sutra Trademark AI platform has not just confirmed decades of work, but also added new targets for monoclonal antibodies within weeks, receiving independent validation of their potential from collaborators. CBDW AI algorithms have identified several promising drug candidates. CBDW has identified a target in the mitochondrial metabolism that has a role in oncology. CBDW then adds them to an ever-growing IP portfolio, including patents, trademarks, and trade secrets, enhancing its competitive advantage and potential for future revenue. The success and validation of the CBDW Sutra Trademark AI platform for AI-discovered drugs are testaments to its capabilities and the future it promises.

CBDW is dedicated to pushing the boundaries of drug discovery with its AI Drug Discovery (AIDD) player, Sutra Trademark . With the CBDW AI-powered structure prediction algorithms, this platform has the potential to revolutionize drug discovery. It can design small molecules, optimize the design of antibodies and other proteins, and even repurpose drug molecules.

With a database of 19 viruses, the CBDW Sutra Trademark AI platform can predict and help prevent future pandemics. With access to a curated library of 8 million molecules, the CBDW platform makes possible the discovery of new drugs that precisely target neutralizable epitopes on viruses to enhance the potency and efficacy of existing therapies. The CBDW Sutra Trademark team's unwavering dedication to leveraging microbiome samples to identify new biomarkers for neurodegenerative diseases instills hope for future medical breakthroughs.

CBDW harnesses the power of AI to revolutionize drug repurposing, offering a cost-effective alternative to developing new drugs from the ground up. Drug repurposing involves identifying potential new applications for existing compounds, which can be time-consuming and labor-intensive. However, AI algorithms can analyze existing drug databases and identify potential new applications for these compounds in a fraction of the time, making it a game-changer in the pharmaceutical industry. CBDW is exploring synergizing AI with suitable linkers between antibodies and drugs to promote multi-drug combinations. This approach will bring new therapeutics to market with more substantial impacts than combination therapies and address unmet medical needs, expediting drug discovery and regulatory approvals.

Strategic Investment to Revolutionize AI-Driven Drug Discovery

On September 17th CBDW announced it had signed a Letter of Intent to acquire a strategic stake in Adnexus Biotechnologies Inc.

This strategic investment exemplifies the CBDW commitment to advancing its technological capabilities and expanding its reach in the AI sector. Integrating cutting-edge AI research and development into its portfolio underscores the CBDW aim to impact the AI sector, healthcare, and biotechnology significantly. This collaboration has the potential to push the boundaries of what is achievable in these fields.

For more information on $CBDW visit https://www.adnexusbiotech [https://www.adnexusbiotech].com

and https://cbdw [https://cbdw.ai/].ai/
Media Contact
Company Name: 1606 Corp.
Contact Person: Gaurav Chandra, CEO
Email: Send Email [http://www.universalpressrelease.com/?pr=generative-ai-chatbots-provide-instant-247-support-for-investors-and-medicinal-queries-while-offering-personalized-recommendations-1606-corp-stock-symbol-cbdw]
Phone: (602) 481-1544
Address:2425 East Camelback Road Suite 150
City: Phoenix
State: AZ 8501
Country: United States
Website: https://www.adnexusbiotech.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generative AI Chatbots Provide Instant, 24/7 Support for Investors and Medicinal Queries While Offering Personalized Recommendations: 1606 Corp (Stock Symbol: CBDW) here

News-ID: 3723938 • Views:

More Releases from Getnews

Weaver International Unveils Document Management System Integrating Office Automation and Business Process Management
Weaver International Unveils Document Management System Integrating Office Autom …
New platform streamlines secure document storage, automated workflows and real-time collaboration for improved operational efficiency. Image: https://www.globalnewslines.com/uploads/2025/02/6e9874bfe8d881ca338796c6bc05e991.jpg Weaver International [https://weaver.com.co/]announced the launch of its new Document Management System [https://weaver.com.co/solutions/document-management-system/], a platform that integrates office automation and business process management to simplify digital collaboration and streamline business operations. The system consolidates secure document storage, automated workflows and real-time collaboration tools into a single platform. Built to support organizations of all sizes, the new solution
Five Star Painting of Cincinnati Expands Services to Meet Growing Demand in Loveland
Five Star Painting of Cincinnati Expands Services to Meet Growing Demand in Love …
Image: https://www.globalnewslines.com/uploads/2025/02/1739365423.jpg Five Star Painting of Cincinnati is enhancing its professional painting services to serve homeowners in Loveland better. With a focus on precision, quality, and customer satisfaction, the company is expanding its offerings to include specialized interior, exterior, and cabinet painting solutions tailored to meet the area's growing residential needs. Recent trends indicate a surge in home improvement projects across Loveland, with many homeowners investing in fresh paint to enhance their
Marlowe's Outdoor Kitchen and Patio Expands High-End Services for Yorktown Homeowners
Marlowe's Outdoor Kitchen and Patio Expands High-End Services for Yorktown Homeo …
Image: https://www.globalnewslines.com/uploads/2025/02/1739371612.jpg Marlowe's Outdoor Kitchen and Patio, a leading provider of luxury outdoor living solutions, has expanded its services to cater specifically to homeowners in Yorktown seeking to elevate their outdoor spaces. With a focus on high-end designs tailored for those over 40, the company now offers enhanced solutions, including Outdoor Kitchens in Yorktown, smokers, and brick paver patios. Marlowe's specializes in crafting custom outdoor kitchens [https://www.google.com/search?kgmid=/g/1tcygbdq] that combine premium functionality with
First Choice Chiropractic LLC Expands Services to Support Car Accident Recovery in Columbus
First Choice Chiropractic LLC Expands Services to Support Car Accident Recovery …
Image: https://www.globalnewslines.com/uploads/2025/02/1739370730.jpg First Choice Chiropractic LLC, a trusted provider of chiropractic care, has announced an enhanced focus on supporting individuals recovering from car accidents. This initiative addresses the growing need for specialized, non-invasive care tailored to injuries commonly sustained in motor vehicle collisions. The expanded services include personalized treatment plans designed to aid recovery from conditions such as whiplash, back pain, and other accident-related injuries. By emphasizing a patient-centered approach, the clinic

All 5 Releases